Lamriga 100mg Tablet DT contains Lamotrigine, an anticonvulsant medication indicated for the management of epilepsy and bipolar disorder. Lamotrigine acts by stabilizing neuronal membranes and modulating voltage-sensitive sodium channels, thereby inhibiting the release of excitatory neurotransmitters such as glutamate and aspartate. This mechanism helps to prevent the initiation and spread of seizure activity in the brain. Lamriga 100mg Tablet DT is specifically formulated as a dispersible tablet, facilitating ease of administration, particularly in patients with swallowing difficulties. It is primarily prescribed for the treatment of partial seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. Additionally, Lamotrigine is used as a mood stabilizer to delay the occurrence of mood episodes in bipolar disorder. The dosage should be individualized based on clinical response and tolerability, with gradual titration recommended to minimize the risk of serious skin reactions such as Stevens-Johnson syndrome. Patients should be monitored regularly for adverse effects including rash, dizziness, headache, and gastrointestinal disturbances. Lamriga 100mg Tablet DT should be used under strict medical supervision, with caution advised in patients with hepatic or renal impairment. It is contraindicated in individuals with known hypersensitivity to Lamotrigine or any excipients.